My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$BHI {{ '2016-05-23T20:11:56+0000' | timeago}} • SEC

In 2016, $BHI expects cash on hand, cash flows from operating activities and the available credit facility to provide with sufficient capital resources & liquidity to manage its working capital needs. $BHI said it may issue commercial paper or other short-term debt in future to fund cash needs in the US in excess of cash generated in the US.

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

$MA {{ '2016-10-28T14:08:29+0000' | timeago}} • Webcast

$MA said it is normal for the company to sign a set of new agreements or renewing agreements in its fourth quarter, just before the year ends. Due to this, more rebates and incentives are expected to come in 4Q16 also which is likely to weigh down on net revenues.

$GT {{ '2016-10-28T14:08:18+0000' | timeago}} • Webcast

$GT's cash and cash equivalents at 3Q16-end were about $1Bil. Total debt is down more than $200MM from 2Q16 and net debt is down slightly as well. The increase versus year-end reflects the normal working capital seasonality in the company's business. The increase versus the prior year period includes the impact of Venezuela's deconsolidation.

$TGNA {{ '2016-10-28T14:06:04+0000' | timeago}} • Announcement

$TGNA's BoD declared a quarterly dividend of 14 cents per share. The dividend is payable on Jan. 3, 2017 to stockholders of record on Dec. 9, 2016.

$GT {{ '2016-10-28T14:01:42+0000' | timeago}} • Webcast

$GT expects to continue its progress toward its 2020 target of $3Bil in segment operating income and $3.5-4.0Bil in returns to shareholders as part of its 2017-2020 capital allocation plan.

$BIIB {{ '2016-10-28T14:00:32+0000' | timeago}} • Announcement

$BIIB said its New Drug Application for nusinersen, investigational treatment for spinal muscular atrophy, has been accepted by the U.S. Food and Drug Administration for Priority Review, and that its Marketing Authorization Application has been validated by the European Medicines Agency. $BIIB plans to market nusinersen under brand name Spinraza.